Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities.

导出 OA

翻译打印收藏纠错

作者： Junko,Masuda ^[1] ; Eiji,Takayama ^[2] ; Warren,Strober ^[3] ; Ayano,Satoh ^[1] ; Yuji,Morimoto ^[4] ; Yasuko,Honjo ^[5] ; Tatsuo,Ichinohe ^[5] ; Shin-Ichi,Tokuno ^[6] ; Toshiaki,Ishizuka ^[7] ; Takahiro,Nakata ^[8] ; Akifumi,Mizutani ^[1] ; Naoki,Umemura ^[2] ; Atsushi,Kitani ^[3] ; Ivan J,Fuss ^[3] ; Tsukasa,Shigehiro ^[1] ; Harumi,Kawaki ^[2] ; Masako,Mizuno-Kamiya ^[2] ; Nobuo,Kondoh ^[2] ; Masaharu,Seno ^[1]

作者单位： Division of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama, Japan. ^[1] Department of Oral Biochemistry, Asahi University School of Dentistry, Gifu, Japan. ^[2] Mucosal Immunity Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. ^[3] Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Saitama, Japan. ^[4] Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. ^[5] Verbal Analysis of Pathophysiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. ^[6] Department of Pharmacology, National Defense Medical College, Saitama, Japan. ^[7] Department of Molecular and Cellular Anatomy, Faculty of Health Promotional Science, Tokoha University, Hamamatsu, Japan. ^[8]